EP
MLAB icon

Elkfork Partners’s Mesa Laboratories MLAB Stock Holding History

Elkfork Partners’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$154K Buy
+646
New +$149K ﹤0.01% 875

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Elkfork Partners's MLAB Position: Q3 2019 in Review

Elkfork Partners opened a new position in Mesa Laboratories (MLAB) in Q3 2019: 646 shares worth $154K. The stake represents ﹤0.01% of the portfolio and ranks #875 among its holdings.

144 funds tracked by Wall St. Rank hold MLAB as of Q3 2019.

  • Elkfork Partners held 646 shares of Mesa Laboratories worth $154K as of Q3 2019.
  • Mesa Laboratories was a new Elkfork Partners position in Q3 2019.
  • Mesa Laboratories made up ﹤0.01% of Elkfork Partners's portfolio in Q3 2019, its #875 holding.
  • 144 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.